13G Filing: Sabby Capital and Taxus Cardium Pharmaceuticals Group Inc. (CRXM)

Page 4 of 8 – SEC Filing

12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

IN?

CUSIP No.
876767104

Item 1.
(a).
Name of Issuer:Taxus Cardium Pharmaceuticals Group, Inc.

(b).
Address of issuer’s principal executive offices:12255 El Camino Real, Suite 250, San Diego, CA 92130

Item 2.
(a).
Name of person filing:Sabby Healthcare Master Fund, Ltd.
Sabby Management, LLC
Hal Mintz(b).
Address or principal business office or, if none, residence:Sabby Healthcare Master Fund, Ltd.
c/o Ogier Fiduciary Services (Cayman) Limited
89 Nexus Way, Camana Bay
Grand Cayman KY1-9007
Cayman Islands

Sabby Management, LLC
10 Mountainview Road, Suite 205
Upper Saddle River, New Jersey 07458

Hal Mintz
c/o Sabby Management, LLC
10 Mountainview Road, Suite 205
Upper Saddle River, New Jersey 07458(c).
Citizenship:Sabby Healthcare Master Fund, Ltd. – Cayman Islands
Sabby Management, LLC – Delaware, USA
Hal Mintz – USA(d).
Title of class of securities:Common stock (the Common Stock), par value $0.001

(e).
CUSIP No.:

Follow Gene Biotherapeutics Inc. (OTCMKTS:CRXM)